Qkine

About:

Qkine is a specialist developer and manufacturer of growth factor proteins for stem cell, organoid and cellular agriculture applications

Website: http://www.qkine.com

Twitter/X: QkineBio

Top Investors: Martlet Capital, Parkwalk Advisors, Jonathan Milner, Downing Ventures, O2h Ventures

Description:

Qkine manufactures high-purity, animal-free growth factors, cytokines and other complex proteins. Based on the Cambridge Science Park, UK, we combine proprietary protein production processes developed at the University of Cambridge with protein engineering techniques to develop unique products that tackle fundamental biological and scale-up challenges for the fast-growing stem cell, organoid, regenerative medicine and cultivated meat sectors. Qkine has an active R&D pipeline, with a continually expanding product range. Unique products available from Qkine include tag-free thermostable FGF-2 (FGF2-G3), the first animal-free TGF beta 1 for chemically defined stem cell media, and animal-free HGF (NK1). Qkine is an ISO 9001: 2015 certified company.

Total Funding Amount:

6.37M GBP

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Cambridge, Cambridgeshire, United Kingdom

Founded Date:

2016-11-01

Contact Email:

info(AT)qkine.com

Founders:

Catherine Elton, Marko Hyvönen

Number of Employees:

11-50

Last Funding Date:

2022-12-15

IPO Status:

Private

Industries:

© 2025 bioDAO.ai